| GTO ID | GTC1783 |
| Trial ID | NCT03282188 |
| Disease | Skin Cancer | Melanoma |
| Therapy | dsRNA |
| Treatment | Reolysin |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | A Clinical Study to Evaluate the Biological Effects of Intravenous Wild-type Reovirus (Reolysin), With of Without GM-CSF, in Advanced Melanoma |
| Year | 2017 |
| Country | United Kingdom |
| Company sponsor | University of Leeds |
| Other ID(s) | MO15/121 |
| Vector information | |||
|
|||
| Cohort1: Reolysin | |||||||||
|
|||||||||
| Cohort2: Reolysin_GM-CSF | |||||||||
|
|||||||||